Tag: izervay
Commonalities in Detection and Management of Patients With DRD and GA
Diabetes-related retinal disease (DRD) and geographic atrophy (GA) represent two significant threats to vision, and their prevalence is steadily increasing, says Sherrol Reynolds, OD,...
New Treatments Drive Doctor’s Proactive Approach to Detecting Geographic Atrophy
Roya Attar, OD, MBA, DHA, director of optometric services at the department of ophthalmology at the University of Mississippi Medical Center, has adjusted her...
The Parallels in Glaucoma and Geographic Atrophy
Jessica Steen, OD, FAAO, of Nova Southeastern University College of Optometry and attending optometric physician at the college’s Eye Care Institute, says that careful...
With Geographic Atrophy Treatment Options Available, Primary Care ODs Play Important...
If there’s one compelling reason why primary care optometrists should be looking for signs of geographic atrophy, it’s this: “We see 88 million comprehensive...
Detecting Geographic Atrophy Is Not Just for Retina Specialists
Cecelia Koetting, OD, FAAO DipABO, of the University of Colorado School of Medicine, specializes in neuro-optometry, anterior segment and ocular surface disease, “but I’m still...
ODs Should Be Proactive in Identifying Patients at Risk for AMD
A patient’s age-related macular degeneration (AMD) at any stage should rise to a high level of importance for optometrists. Imaging is important to feel...
Iveric Bio Receives U.S. FDA Approval for IZERVAY™ (avacincaptad pegol intravitreal...
– IZERVAY is the only approved GA treatment with a statistically significant reduction in the rate of GA progression at the 12-month primary endpoint across...
